{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:37:41Z","timestamp":1792075061451,"version":"4.4.0"},"reference-count":103,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1093\/jac\/dkx349","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T11:09:06Z","timestamp":1504264146000},"page":"1-11","source":"Crossref","is-referenced-by-count":244,"title":["Daptomycin"],"prefix":"10.1093","volume":"73","author":[{"given":"Mohsen","family":"Heidary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azar Dohkt","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Khoshnood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Javad","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Goudarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,10,20]]},"reference":[{"key":"key\n\t\t\t\t20171215014817_dkx349-B1","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1128\/AAC.00202-07","article-title":"Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF","volume":"51","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jac\/46.4.523","article-title":"Development of daptomycin for gram-positive infections","volume":"46","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/JCM.44.2.595-597.2006","article-title":"Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis","volume":"44","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jinf.2006.11.007","article-title":"Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients","volume":"54","year":"2007","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/CMR.00030-13","article-title":"A current perspective on daptomycin for the clinical microbiologist","volume":"26","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B6","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1128\/AAC.49.4.1664-1665.2005","article-title":"Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B7","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.7164\/antibiotics.41.1093","article-title":"Enzymatic and chemical modifications of lipopeptide antibiotic A21978C: the synthesis and evaluation of daptomycin (LY146032)","volume":"41","year":"1988","journal-title":"J Antibiot"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbamem.2011.10.027","article-title":"Characterization of daptomycin oligomerization with perylene excimer fluorescence: stoichiometric binding of phosphatidylglycerol triggers oligomer formation","volume":"1818","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00249-007-0227-2","article-title":"Effect of divalent cations on the structure of the antibiotic daptomycin","volume":"37","year":"2008","journal-title":"Eur Biophys J"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B10","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/jac\/dkn321","article-title":"Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus","volume":"62","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B11","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1128\/AAC.45.6.1919-1922.2001","article-title":"In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers","volume":"45","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jac\/31.2.227","article-title":"The activity of daptomycin on Enterococcus faecium protoplasts: indirect evidence supporting a novel mode of action on lipoteichoic acid synthesis","volume":"31","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B13","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/AAC.34.6.1220","article-title":"Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032)","volume":"34","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B14","first-page":"52","article-title":"The interplay between daptomycin and the immune system","volume":"5","year":"2014","journal-title":"Front Immunol"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jac\/dkr417","article-title":"Concentration-dependent effects of antimicrobials on Staphylococcus aureus toxin-mediated cytokine production from peripheral blood mononuclear cells","volume":"67","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000108106","article-title":"Daptomycin does not exert immunomodulatory effects in an experimental endotoxin model of human whole blood","volume":"81","year":"2008","journal-title":"Pharmacology"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/ja.2015.18","article-title":"Linezolid, vancomycin and daptomycin modulate cytokine production, Toll-like receptors and phagocytosis in a human in vitro model of sepsis","volume":"68","year":"2015","journal-title":"J Antibiot"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B18","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1128\/AAC.00973-06","article-title":"Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and\/or rifampin in human monocytes and in broth against Staphylococcus aureus","volume":"51","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/jac\/22.2.185","article-title":"Intraphagocytic penetration of antibiotics","volume":"22","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B20","first-page":"219","article-title":"Immunomodulatory effects of fosfomycin in an endotoxin model in human blood","volume":"59","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1473-3099(03)00658-3","article-title":"Immunomodulatory effects of quinolones","volume":"3","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s15010-005-8209-8","article-title":"Immunomodulatory activities of fluoroquinolones","volume":"33","year":"2005","journal-title":"Infection"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1469-0691.2006.01625.x","article-title":"Test results: characterising the antimicrobial activity of daptomycin","volume":"12","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B24","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1128\/AAC.00735-16","article-title":"New insight into daptomycin bioavailability and localization in Staphylococcus aureus biofilms by dynamic fluorescence imaging","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B25","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/AAC.00350-06","article-title":"Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm","volume":"51","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B26","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1093\/jac\/dks272","article-title":"Activity of linezolid and high-dose daptomycin, alone or in combination, in an in vitro model of Staphylococcus aureus biofilm","volume":"67","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0196-4399(02)80007-1","article-title":"Daptomycin: a novel lipopeptide antibiotic","volume":"24","year":"2002","journal-title":"Clin Microbiol News"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jac\/dkh143","article-title":"Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms","volume":"53","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B29","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ejvs.2010.08.009","article-title":"Daptomycin and rifampin alone and in combination prevent vascular graft biofilm formation and emergence of antibiotic resistance in a subcutaneous rat pouch model of staphylococcal infection","volume":"40","year":"2010","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B30","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1128\/AAC.01728-08","article-title":"Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B31","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/cid\/ciu642","article-title":"Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faecium harboring LiaSR substitutions","volume":"59","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B32","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/cid\/civ449","article-title":"Editorial commentary: linezolid vs daptomycin for vancomycin-resistant enterococci: the evidence gap between trials and clinical experience","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.20506\/rst.31.1.2096","article-title":"Antimicrobial agents targeting bacterial cell walls and cell membranes","volume":"31","year":"2012","journal-title":"Rev Sci Tech"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/AAC.02005-12","article-title":"The target of daptomycin is absent from Escherichia coli and other Gram-negative pathogens","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B35","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1128\/AAC.00090-07","article-title":"Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells","volume":"51","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B36","first-page":"578251","article-title":"Daptomycin: local application in implant-associated infection and complicated osteomyelitis","volume":"2012","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1749-6632.2012.06819.x","article-title":"Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall","volume":"1277","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B38","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1093\/cid\/civ523","article-title":"Evolving resistance among Gram-positive pathogens","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B39","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/jac\/dkr195","article-title":"Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach","volume":"66","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B40","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1128\/AAC.00774-07","article-title":"Mechanisms of resistance to daptomycin in Enterococcus faecium","volume":"52","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B41","doi-asserted-by":"crossref","first-page":"e1076","DOI":"10.1016\/j.ijid.2013.02.019","article-title":"In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis","volume":"17","year":"2013","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nyas.12948","article-title":"Mechanisms of drug resistance: daptomycin resistance","volume":"1354","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B43","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1086\/520655","article-title":"Perspectives on daptomycin resistance, with emphasis on resistance in Staphylococcus aureus","volume":"45","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/CMR.00058-14","article-title":"Antimicrobial heteroresistance: an emerging field in need of clarity","volume":"28","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B45","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/AAC.00437-10","article-title":"An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus","volume":"54","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B46","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1128\/AAC.01303-15","article-title":"Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B47","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1126\/science.1120800","article-title":"Sampling the antibiotic resistome","volume":"311","year":"2006","journal-title":"Science"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B48","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jac\/dkh104","article-title":"Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci","volume":"53","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B49","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/jac\/dkm045","article-title":"Daptomycin-reversible rifampicin resistance in vancomycin-resistant Enterococcus faecium","volume":"59","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B50","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1128\/AAC.05551-11","article-title":"Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B51","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1128\/AAC.01455-06","article-title":"Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology","volume":"51","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B52","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1128\/AAC.00051-09","article-title":"Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B53","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1128\/AAC.49.7.2735-2745.2005","article-title":"Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B54","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1128\/AAC.00290-06","article-title":"Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species","volume":"50","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijantimicag.2009.12.022","article-title":"In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin\/clavulanic acid or ampicillin","volume":"35","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B56","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.diagmicrobio.2011.07.001","article-title":"Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia","volume":"71","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B57","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3390\/genes6041256","article-title":"Daptomycin-nonsusceptible Staphylococcus aureus: the role of combination therapy with daptomycin and gentamicin","volume":"6","year":"2015","journal-title":"Genes (Basel)"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B58","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/jac\/dkv368","article-title":"When sepsis persists: a review of MRSA bacteraemia salvage therapy","volume":"71","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B59","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/AAC.02071-15","article-title":"Penicillin binding protein 1 is important in the compensatory response of Staphylococcus aureus to daptomycin-induced membrane damage and is a potential target for \u03b2-lactam\u2013daptomycin synergy","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B60","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00109-013-1100-7","article-title":"Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus","volume":"92","year":"2014","journal-title":"J Mol Med"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B61","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1128\/AAC.48.8.2871-2875.2004","article-title":"Synergy of daptomycin with oxacillin and other \u03b2-lactams against methicillin-resistant Staphylococcus aureus","volume":"48","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/infdis\/jiw464","article-title":"Redeploying \u03b2-lactams against Staphylococcus aureus: repurposing with a purpose","volume":"215","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B63","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/cid\/cir340","article-title":"Use of antistaphylococcal \u03b2-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding","volume":"53","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B64","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13063-016-1295-3","article-title":"CAMERA2\u2014combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial","volume":"17","year":"2016","journal-title":"Trials"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B65","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1469-0691.2006.01342.x","article-title":"The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram\u2010positive bacteria","volume":"12","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B66","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1128\/AAC.01604-15","article-title":"Observed antagonistic effect of linezolid on daptomycin or vancomycin activity against biofilm-forming methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B67","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/cid\/ciw173","article-title":"Influence of minimum inhibitory concentration in clinical outcomes of Enterococcus faecium bacteremia treated with daptomycin: is it time to change the breakpoint?","volume":"62","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B68","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jac\/20.2.191","article-title":"Comparative in-vitro activity of LY146032 a new peptolide, with vancomycin and eight other agents against gram-positive organisms","volume":"20","year":"1987","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B69","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nrd1258","article-title":"Daptomycin","volume":"2","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B70","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1099\/jmm.0.022533-0","article-title":"Six cases of daptomycin-non-susceptible Staphylococcus aureus bacteraemia in Singapore","volume":"59","year":"2010","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B71","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jac\/dkg130","article-title":"Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000\u20132001","volume":"51","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B72","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.diagmicrobio.2013.01.001","article-title":"Antimicrobial activity of daptomycin tested against Gram-positive pathogens collected in Europe, Latin America, and selected countries in the Asia-Pacific Region (2011)","volume":"75","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B73","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1517\/14656561003598893","article-title":"Daptomycin: pharmacology and clinical use","volume":"11","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B74"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B75","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1128\/JCM.43.10.5384-5387.2005","article-title":"Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin","volume":"43","year":"2005","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B76","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ijantimicag.2014.01.018","article-title":"Daptomycin activity tested against 164457 bacterial isolates from hospitalised patients: summary of 8\u2009years of a Worldwide Surveillance Programme (2005\u20132012)","volume":"43","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B77","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/JCM.43.10.5285-5287.2005","article-title":"Development of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus","volume":"43","year":"2005","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B78","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1086\/428616","article-title":"Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia","volume":"40","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B79","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/jac\/dkl256","article-title":"Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy","volume":"58","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B80","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/JCM.44.2.655-656.2006","article-title":"Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin","volume":"44","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B81","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1086\/502688","article-title":"Diminished susceptibility to daptomycin accompanied by clinical failure in a patient with methicillin-resistant Staphylococcus aureus bacteremia","volume":"27","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B82","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1128\/AAC.00559-07","article-title":"Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis","volume":"51","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B83","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10096-007-0455-5","article-title":"High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia","volume":"27","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B84","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/JCM.01844-07","article-title":"Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan","volume":"46","year":"2008","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B85","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/JCM.00660-07","article-title":"Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin","volume":"46","year":"2008","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B86","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.diagmicrobio.2007.11.002","article-title":"Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus","volume":"60","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B87","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1099\/jmm.0.2008\/000588-0","article-title":"Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate","volume":"57","year":"2008","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B88","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/591280","article-title":"Fatal bacteremic mycotic aneurysm complicated by acute renal failure caused by daptomycin-nonsusceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus","volume":"47","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B89","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1099\/jmm.0.006486-0","article-title":"In vivo development of heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA), GISA and daptomycin resistance in a patient with meticillin-resistant S. aureus endocarditis","volume":"58","year":"2009","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B90","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ijantimicag.2008.12.010","article-title":"Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy","volume":"33","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B91","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10096-008-0692-2","article-title":"Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE)","volume":"28","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B92","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijantimicag.2008.06.028","article-title":"Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease","volume":"33","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B93","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3109\/00365548.2010.524662","article-title":"Daptomycin non-susceptible, vancomycin intermediate methicillin-resistant Staphylococcus aureus ST398 from a chronic leg ulcer, Italy","volume":"42","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B94","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1128\/AAC.00533-10","article-title":"Development of daptomycin nonsusceptibility with heterogeneous vancomycin-intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment","volume":"54","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B95","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s15010-011-0103-y","article-title":"Glycopeptide and daptomycin resistance in community-associated MRSA in the UK","volume":"39","year":"2011","journal-title":"Infection"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B96","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10096-010-1128-3","article-title":"Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-na\u00efve patient\u2014a review of the literature","volume":"30","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B97","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2334-11-152","article-title":"High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: case report","volume":"11","year":"2011","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B98","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1111\/j.1399-3062.2012.00775.x","article-title":"Successful treatment of a left ventricular assist device infection with daptomycin non\u2010susceptible methicillin\u2010resistant Staphylococcus aureus: case report and review of the literature","volume":"14","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B99","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.3928\/01477447-20120327-42","article-title":"Daptomycin resistance in prosthetic joint infections","volume":"35","year":"2012","journal-title":"Orthopedics"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B100","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1155\/2012\/138470","article-title":"Daptomycin-nonsusceptible, vancomycin-intermediate, methicillin-resistant Staphylococcus aureus endocarditis","volume":"23","year":"2012","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B101","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/jac\/dkt009","article-title":"Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report","volume":"68","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B102","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/1469-0691.12171","article-title":"Daptomycin non\u2010susceptible Staphylococcus aureus at a US medical centre","volume":"19","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20171215014817_dkx349-B103","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jac\/dkt396","article-title":"Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin","volume":"69","year":"2014","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/1\/1\/22755643\/dkx349.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T01:31:37Z","timestamp":1570066297000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/73\/1\/1\/4558667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,20]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,10,20]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx349","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,10,20]]}}}